Next Generation Sequencing (DNA and RNA) clinical trials

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

This study looks at children with a type of blood cancer called Chronic Myeloid Leukaemia (CML). We're exploring if specific genetic changes can help predict how well children will respond to common CML medicines called TKIs. This could help doctors choose the best treatment.